Jeff Johnson
Stock Analyst at Baird
(4.63)
# 207
Out of 5,120 analysts
152
Total ratings
57.69%
Success rate
28.41%
Average return
Main Sectors:
Stocks Rated by Jeff Johnson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNDM Tandem Diabetes Care | Upgrades: Outperform | $18 → $30 | $20.09 | +49.33% | 17 | Dec 16, 2025 | |
| ZBH Zimmer Biomet Holdings | Downgrades: Neutral | $117 → $100 | $86.22 | +15.98% | 15 | Dec 16, 2025 | |
| COO The Cooper Companies | Maintains: Outperform | $85 → $98 | $80.65 | +21.51% | 19 | Dec 5, 2025 | |
| ALC Alcon | Maintains: Outperform | $95 → $98 | $79.38 | +23.46% | 11 | Nov 13, 2025 | |
| DXCM DexCom | Maintains: Outperform | $112 → $90 | $72.53 | +24.09% | 15 | Sep 26, 2025 | |
| BBNX Beta Bionics | Maintains: Neutral | $15 → $17 | $13.70 | +24.09% | 2 | Jul 30, 2025 | |
| HSIC Henry Schein | Downgrades: Neutral | $82 → $72 | $75.31 | -4.40% | 10 | Jul 14, 2025 | |
| NVST Envista Holdings | Upgrades: Outperform | $21 → $23 | $23.26 | -1.12% | 10 | May 27, 2025 | |
| SYK Stryker | Maintains: Outperform | $378 → $405 | $368.14 | +10.01% | 11 | Oct 30, 2024 | |
| ALGN Align Technology | Maintains: Outperform | $325 → $276 | $163.63 | +68.67% | 18 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $180 → $238 | $256.62 | -7.26% | 12 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $67 → $70 | $22.17 | +215.74% | 2 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $53 → $61 | $16.62 | +267.03% | 4 | Jul 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $78 → $67 | $12.21 | +448.73% | 6 | Feb 18, 2022 |
Tandem Diabetes Care
Dec 16, 2025
Upgrades: Outperform
Price Target: $18 → $30
Current: $20.09
Upside: +49.33%
Zimmer Biomet Holdings
Dec 16, 2025
Downgrades: Neutral
Price Target: $117 → $100
Current: $86.22
Upside: +15.98%
The Cooper Companies
Dec 5, 2025
Maintains: Outperform
Price Target: $85 → $98
Current: $80.65
Upside: +21.51%
Alcon
Nov 13, 2025
Maintains: Outperform
Price Target: $95 → $98
Current: $79.38
Upside: +23.46%
DexCom
Sep 26, 2025
Maintains: Outperform
Price Target: $112 → $90
Current: $72.53
Upside: +24.09%
Beta Bionics
Jul 30, 2025
Maintains: Neutral
Price Target: $15 → $17
Current: $13.70
Upside: +24.09%
Henry Schein
Jul 14, 2025
Downgrades: Neutral
Price Target: $82 → $72
Current: $75.31
Upside: -4.40%
Envista Holdings
May 27, 2025
Upgrades: Outperform
Price Target: $21 → $23
Current: $23.26
Upside: -1.12%
Stryker
Oct 30, 2024
Maintains: Outperform
Price Target: $378 → $405
Current: $368.14
Upside: +10.01%
Align Technology
Oct 24, 2024
Maintains: Outperform
Price Target: $325 → $276
Current: $163.63
Upside: +68.67%
Dec 21, 2023
Upgrades: Outperform
Price Target: $180 → $238
Current: $256.62
Upside: -7.26%
Aug 4, 2023
Maintains: Outperform
Price Target: $67 → $70
Current: $22.17
Upside: +215.74%
Jul 28, 2023
Maintains: Outperform
Price Target: $53 → $61
Current: $16.62
Upside: +267.03%
Feb 18, 2022
Maintains: Outperform
Price Target: $78 → $67
Current: $12.21
Upside: +448.73%